Federico Asch, M.D., FASE, director of cardiovascular core labs, cardiovascular imaging, MedStar...
-
-
June 29, 2021 – A new original science category being featured at the American Society of Echocardiography (ASE) 2021...
-
Here are the top 10 takeaways from the late-breaking studies on cardiovascular technologies presented at the 2021 American College of Cardiology (ACC...
-
June 7, 2021 — A couple years ago a study showed a mortality safety signal in patients who underwent peripheral artery disease (PAD) revascularization with paclitaxel drug-coated devices.
News | PET-CT | July 13, 2021
July 13, 2021 — In a recent blog, the American Society of Nuclear Cardiology (ASNC) reported that Humana, one of the...
Videos | Artificial Intelligence | July 01, 2021
Federico Asch, M.D., FASE, director of cardiovascular core labs, cardiovascular imaging, MedStar Health Research...
Getty Images
News | Cardiovascular Ultrasound | June 29, 2021
June 29, 2021 – A new original science category being featured at the American Society of Echocardiography (ASE) 2021...
Getty Images
News | Womens Cardiovascular Health | June 29, 2021
June 29, 2021 – Three research studies presented at the American Society of Echocardiography (ASE) 2021 virtual meeting...
Images from the ASE presentation. Left, UEA echo showing focal narrowing of the SCPC anastomosis and the same view on invasive angiography. Right, UAE echo showing complete occlusion of pulmonary artery and angiography showing the same view.
News | Congenital Heart | June 29, 2021
June 29, 2021 – Echocardiography with ultrasound enhancing agents (UEAs) has proven to be a valuable imaging procedure...
New cardiac ultrasound technologies featured at the 2021 ASE meeting include intracardiac ultrasound (ICE) imaging from Biosense Webster (left), and cloud-based, vendor-neutral strain imaging from Epsilon Imaging (right).
News | ASE | June 29, 2021
June 29, 2021 – The virtual exhibit hall at American Society of Echocardiography (ASE) 2021 Scientific Sessions Virtual...
News | Artificial Intelligence | June 28, 2021
June 28, 2021 — Circle Cardiovascular Imaging Inc. and DiA Imaging Analysis Ltd. entered into a multi-year partnership...
Getty Images
News | Artificial Intelligence | June 25, 2021
June 25, 2021 – COVID-19 changed everything in healthcare, and a benefit from this pandemic was a surge in innovations...
Clinical trial quality data can be derived from national cardiovascular registries, which may change how trials are performed in the future. Getty Images
News | Cardiovascular Clinical Studies | June 24, 2021
June 24, 2021 — Data captured in American College of Cardiology (ACC) National Cardiovascular Data Registry (NCDR)...
Prediction performance of DL compared to quantitative measures and Kaplan-Meier curves for quartiles of DL. Image created by Singh et al., Cedars-Sinai Medical Center, Los Angeles, CA.
News | SPECT Imaging | June 14, 2021
June 14, 2021 — An advanced artificial intelligence technique known as deep learning can predict major adverse cardiac...
GE is integrating artificial intelligence into most of its imaging and information technology software. AI can aid fast critical care decision making. Above left is the vScan Air wireless point-of-care ultrasound system. It integrates AI for immediate, automated assessment of a patient's ejection fraction, right.
Feature | Artificial Intelligence | June 10, 2021
The digital transformation of healthcare is underway, but it will advance further and faster if key stakeholders work...
Blog | Structural Heart | June 08, 2021
It is brutal and very expensive to bring a new transcatheter valve to market. Boston Scientific invested vast amounts...
Some of the top technology news from ACC 2021. Top left, the LAAOS III trial showed benefit when surgeons seal off the LAA during other open heart procedures. Bottom left, the ReCor Paradise renal denervation system helped lower blood pressure in patients who did not respond to medication. Top right, for patients with both heart failure and AFib it makes no difference if therapy is focused on controlling the heart rhythm or heart rate. Bottom right, the FLOWER-MI trial found no benefit to FFR-guided PCI in STEMI with multi-vessel disease.
Feature | ACC | June 08, 2021 | By Dave Fornell, Editor
Here are the top 10 takeaways from the late-breaking studies on cardiovascular technologies presented at the 2021...
Two years ago a study raised concerns that paclitaxel-coated devices may cause increased mortality in peripheral artery disease patients. However, numerous studies now show there is no risk of increased mortality. The most recent study is the SAFE-PAD study presented at ACC.21.
News | Peripheral Artery Disease (PAD) | June 07, 2021
June 7, 2021 — A couple years ago a study showed a mortality safety signal in patients who underwent peripheral artery...
The 30-day outcomes from the TRISCEND study of the transfemoral Evoque tricuspid valve replacement system demonstrated technical feasibility and an acceptable safety profile, along with improvements in tricuspid regurgitation (TR) and symptoms in patients with clinically significant TR.
News | Structural Heart | June 07, 2021
June 7, 2021 — Edwards Lifesciences recently announced that clinical results from the company's transcatheter mitral...
